foto london banner.jpg

Something Powerful

Tell The Reader More

The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.

Remember:

  • Bullets are great
  • For spelling out benefits and
  • Turning visitors into leads.

Interview with NeuroVive’s Erik Kinnman

Erik Kinnman, Chief Executive Officer at Sweden’s NeuroVive Pharmaceutical,...

Read More

Interview with PDL BioPharma’s Peter Garcia

Peter Garcia, Vice President and Chief Financial Officer at Nevada-based, p...

Read More

Interview with Quantum Genomics’ Lionel Segard

Lionel Segard, Chairman and Chief Executive Officer at Quantum Genomics, pr...

Read More

Interview with Heat Biologics’ John Prendergast

John Prendergast, Lead Independent Director at North Carolina-based Nasdaq-...

Read More

Interview with Nuevolution’s Henrik Simonsen

Henrik Simonsen, Chief Financial Officer at Nuevolution, outlines the progr...

Read More

Interview with Therapix Biosciences’ Josh Blacher

Josh Blacher, Chief Financial Officer at Therapix Biosciences, talks throug...

Read More

Interview with Race Oncology’s Peter Molloy

Peter Molloy, Chief Executive Officer at ASX-listed Race Oncology, talks th...

Read More

Interview with VolitionRx’s Cameron Reynolds

Cameron Reynolds, President and Chief Executive Officer at VolitionRx, disc...

Read More

[VIDEO INTERVIEW] Developing Cellular Immunotherap...

Straight from the Investment for Advanced Therapies hosted by CMS Cameron-M...

Read More

[Video Interview] The impact of Brexit on the Brit...

With the date for Brexit rapidly approaching, the realisation is hitting ho...

Read More

[Video interview] What are the challenges for earl...

As Phacilitate prepares to launch their Investment in Advanced Therapies Su...

Read More

Inv€$table CEO Pitch Series: Simon Newman, CSO of ...

At the Inv€$table CEO Pitch Breakfast hosted by K&L Gates on Tuesday 24th M...

Read More

Add Your Response